# Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19

> **NCT04387240** · PHASE2 · WITHDRAWN · sponsor: **Princess Nourah Bint Abdulrahman University**

## Conditions studied

- Covid 19 Positive
- Corona Virus Infection

## Interventions

- **DRUG:** Artemisinin / Artesunate
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT04387240
- **Lead sponsor:** Princess Nourah Bint Abdulrahman University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01
- **Primary completion:** 2022-09
- **Final completion:** 2022-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** did not get enough fund and IRB request
- **Last updated:** 2022-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04387240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04387240, "Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04387240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*